What if you'd held PPCB?
A $1,000 investment in Propanc Biopharma, Inc. (PPCB) at the month-end close of 2013-01 would be worth $0.00000000 at the close of 2026-08 — -100.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $5,145.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2013
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2013 | $1,000 | — |
| 2014 | $15.00 | -98.5% |
| 2015 | $279 | +1760.0% |
| 2016 | $86.00 | -69.2% |
| 2017 | $5.60 | -93.5% |
| 2018 | $0.77 | -86.2% |
| 2019 | $0.03 | -96.1% |
| 2020 | $0.0000224 | -99.9% |
| 2021 | $0.00000352 | -84.3% |
| 2022 | $0.00000005 | -98.6% |
| 2023 | $0.00000000 | -98.0% |
| 2024 | $0.00000000 | -98.3% |
| 2025 | $0.00000002 | +134050.0% |
| 2026 | $0.00000000 | -91.5% |
Best and worst month-end to buy
The best single month-end close to have bought PPCB was 2024-12 ($0.01): $1,000 then is $114,000 today. The worst was 2013-03 ($6250B): $1,000 then is $0.00000000.
FAQ
What would $1,000 in PPCB be worth today?
A $1,000 investment in Propanc Biopharma, Inc. (PPCB) at the start of 2013 would be worth about $0.00000000 today, a total return of -100.0%. Dividends are reinvested in these figures.
What were the best and worst years for PPCB?
Propanc Biopharma, Inc. (PPCB)'s strongest calendar year since 2013 was 2025, a +134050.0% return — $1,000 held through that year became about $1.34M by year-end. Its weakest year was 2020, at -99.9%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in PPCB have grown?
Investing $100 at the end of every month since 2013-01 would have grown to about $51,179 on $16,400 invested.
Did PPCB beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $5,145. PPCB trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Propanc Biopharma, Inc. (PPCB) historical total-return data from 2013-01 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.